1.
Pappagallo G, Rizzo M. Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial:  . CBN [Internet]. 2014 Oct. 15 [cited 2024 Nov. 23];2(2):39-41. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/274